Cas:10001-13-5 cyclohexyl-(4-methylpiperazin-1-yl)methanone manufacturer & supplier

Chemical Name:cyclohexyl-(4-methylpiperazin-1-yl)methanone

CAS.NO:10001-13-5

Synonyms:N’-Cyclohexylcarbonyl-N-methylpiperazin;1-cyclohexanecarbonyl-4-methyl-piperazine;Pexantel;Pexantel [INN]

Molecular Formula:C₁₂H₂₂N₂O

Molecular Weight:210.31600

HS Code:2933599090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:339.9ºC at 760mmHg

Density:1.039g/cm3

Index of Refraction:1.51

PSA:23.55000

Exact Mass:210.17300

LogP:1.21650

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N’-Cyclohexylcarbonyl-N-methylpiperazin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pexantel [INN] physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pexantel Use and application,N’-Cyclohexylcarbonyl-N-methylpiperazin technical grade,usp/ep/jp grade.

Related News: INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. cyclohexyl-(4-methylpiperazin-1-yl)methanone manufacturer Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. cyclohexyl-(4-methylpiperazin-1-yl)methanone supplier Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. cyclohexyl-(4-methylpiperazin-1-yl)methanone vendor US citizens who have been to China in the last 14 days need to re-book to one of seven gateway airports: John F. Kennedy International Airport in New York, Los Angeles International Airport, Seattle, San Francisco International Airport, Chicago, Atlanta and Honolulu. cyclohexyl-(4-methylpiperazin-1-yl)methanone factory INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.